HbA1c Variability as an Independent Risk Factor for Microvascular Complications in Type 1 Diabetes
Authors:
- 2 June 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 18 (2) , 380-388
Abstract
Background: There are few studies on the role of long-term glycemic variability in complications of type 1 diabetes (T1D). This study was aimed to investigate the associations of HbA1c variability represented by the coefficient of variation of HbA1c with incident microvascular complications in T1D by analyzing the data set from the DCCT/EDIC study. Methods: Patients (n = 1240) were divided into four groups by HbA1c variability quartiles. Incident microvascular complications were assessed for a duration of an average of 20.5 years. Multivariable models were performed to examine the associations between HbA1c variability and incident microvascular complications. Results: All incident microvascular complications were higher in the fourth quartile of the HbA1c variability group. After adjusting for clinical risk factors, HbA1c variability was positively associated with a higher risk of all diabetic microvascular complications ( P < .05). Specifically, it had 1.125 (1.082-1.170), 1.114 (1.074-1.154), 1.061 (1.024-1.099), or 1.088 (1.052-1.125) times higher odds (95% confidence interval [CI]) of having retinopathy, nephropathy, clinical neuropathy, or autonomic neuropathy, independent of mean HbA1c values ( P < .05). Furthermore, there were higher incident microvascular complications with higher HbA1c variability when HbA1c value was above the group median of 7.9%, while only higher incident autonomic neuropathy with higher HbA1c variability when HbA1c was below the group median. Conclusions: Our results showed a significant independent association between HbA1c variability and the risk of microvascular complications in T1D. HbA1c variability might be a supplemental risk stratification tool to mean HbA1c for microvascular complications in T1D.Keywords
This publication has 24 references indexed in Scilit:
- Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetesDiabetes, Obesity and Metabolism, 2013
- The rise and fall of HbA1c as a risk marker for diabetes complicationsDiabetologia, 2012
- A1C Variability as an Independent Risk Factor for Microalbuminuria in Young People With Type 1 DiabetesDiabetes Care, 2011
- Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literatureDiabetes, Obesity and Metabolism, 2010
- A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 DiabetesDiabetes, 2009
- A1C Variability and the Risk of Microvascular Complications in Type 1 DiabetesDiabetes Care, 2008
- Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—RevisitedDiabetes, 2008
- Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC)Diabetologia, 2007
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993